How big is the Oligonucleotide Synthesis Market?

The Oligonucleotide Synthesis Market size is expected to reach USD 3.42 billion in 2024 and grow at a CAGR of 12.34% to reach USD 6.12 billion by 2029. Read More

What is the current Oligonucleotide Synthesis Market size?

In 2024, the Oligonucleotide Synthesis Market size is expected to reach USD 3.42 billion. Read More

Who are the key players in Oligonucleotide Synthesis Market?

Thermo Fisher Scientific, Agilent Technologies, Merck KGaA, Bio-Synthesis Inc and Eurofins Scientific are the major companies operating in the Oligonucleotide Synthesis Market. Read More

Which is the fastest growing region in Oligonucleotide Synthesis Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Oligonucleotide Synthesis Market?

In 2024, the North America accounts for the largest market share in Oligonucleotide Synthesis Market. Read More

What years does this Oligonucleotide Synthesis Market cover, and what was the market size in 2023?

In 2023, the Oligonucleotide Synthesis Market size was estimated at USD 3.00 billion. The report covers the Oligonucleotide Synthesis Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Oligonucleotide Synthesis Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

What are the key challenges faced in the Oligonucleotide Synthesis Market?

The key challenges faced in the Oligonucleotide Synthesis Market are a) Strict regulations governing the safety and efficacy of oligonucleotides can create hurdles for market entry and extend development timelines b) Advancements in other gene editing or therapeutic technologies may pose competition for oligonucleotide-based therapies Read More

What are the key challenges faced in the Oligonucleotide Synthesis Market?

The key challenges faced in the Oligonucleotide Synthesis Market are a) Strict regulations governing the safety and efficacy of oligonucleotides can create hurdles for market entry and extend development timelines b) Advancements in other gene editing or therapeutic technologies may pose competition for oligonucleotide-based therapies Read More

Oligonucleotide Synthesis Market Report | Industry Analysis, Size & Forecast Overview

Oligonucleotide Synthesis Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Global Oligonucleotide Market Outlook & Size. The Market is Segmented by Product Type (Synthesized Oligonucleotide Products, Reagents, Equipment, and Services), Application (Research, Therapeutics, and Diagnostics), End-User (Academic Research Institutes, Pharmaceutical and Biotechnology Companies, and Hospital and Diagnostic Laboratories), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Market Size and Forecasts are Provided in Terms of Value (in USD Million) for the Above Segments.

Oligonucleotide Synthesis Industry Overview

The market is fragmented with the presence of a large number of players adopting various strategies, such as the acquisition of players in emerging markets, distribution partnerships, and collaboration for the development of novel technologies. The companies operating in the oligonucleotide synthesis industry are also expanding and developing their product portfolios, which helps drive the overall market and makes it fairly competitive. Some of the companies which are currently dominating the market are Agilent Technologies, Thermo Fisher Scientific, Merck KGaA, Danaher Corporation, Bio-Synthesis Inc., Eurofins Scientific, Kaneka Corporation (Eurogentec), GenScript, and LGC Limited (LGC Biosearch Technologies).